Health Trials

Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger Ovulation in Hyper-responders

ConditionInfertility
Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexFemale
Age18-40
SponsorBedaya Hospital

About this trial

The aim of this randomized controlled study is to compare the efficacy of three successive doses of a GnRH agonist ( administered 36 , 24 and 12 hours before oocyte retrieval ) with a single dose of a GnRH agonist ( administered 36 hours before oocyte retrieval ) in triggering ovulation in hyper-responders

Eligibility criteria

Qualifiers

GnRH antagonist IVF cycle

Hyper-responders to induction of ovulation

Disqualifiers

Hypogonadotrophic hypogonadism

Endometriosis

History of recurrent abortion

Trial design

Treatments tested in this trial

  • Successive doses GnRH agonist
  • Single dose GnRH agonist

Treatment groups

190 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Bedaya Hospital

Lead sponsor

Source ClinicalTrials.gov